2023 Archives
You are viewing archived information from 2023
SB857 SD1    Pdf File  
Measure Title: RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
Report Title: Right-to-Try Act; Terminally Ill Patients; Investigational Drugs; Biological Products
Description: Beginning on January 1, 2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 12/31/2050. (SD1)
Companion:  HB966
Package: None
Current Referral: HHS, CPN/JDC
Introducer(s): CHANG, KEITH-AGARAN, MCKELVEY, Dela Cruz, Kidani
Act:

Sort by Date Status Text
2/17/2023SReport adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/JDC.
2/17/2023SReported from HHS (Stand. Com. Rep. No. 449) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/JDC.
2/6/2023SThe committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Moriwaki, Shimabukuro, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
2/3/2023SThe committee(s) on HHS has scheduled a public hearing on 02-06-23 1:00PM; Conference Room 225 & Videoconference.
1/27/2023SReferred to HHS, CPN/JDC.
1/23/2023SPassed First Reading.
1/20/2023SIntroduced.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB857 SD1
All Versions of this Measure

Committee Reports


Hearing Notices
HHS
2/06/23 1:00P
CR 225 & Videoconference